ENCOMPASS PREECLAMPSIA SCREEN Trademark

Trademark Overview

On Wednesday, August 17, 2022, a trademark application was filed for ENCOMPASS PREECLAMPSIA SCREEN with the United States Patent and Trademark Office. The USPTO has given the ENCOMPASS PREECLAMPSIA SCREEN trademark a serial number of 97552029. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Tuesday, October 29, 2024. This trademark is owned by Mirvie, Inc.. The ENCOMPASS PREECLAMPSIA SCREEN trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes
encompass preeclampsia screen

General Information

Serial Number97552029
Word MarkENCOMPASS PREECLAMPSIA SCREEN
Filing DateWednesday, August 17, 2022
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes
NOT AVAILABLE"PREECLAMPSIA SCREEN"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMirvie, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameMirvie, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Saturday, August 20, 2022NEW APPLICATION ENTERED
Wednesday, September 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 2, 2023ASSIGNED TO EXAMINER
Thursday, June 15, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, June 15, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, June 15, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 15, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, June 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 18, 2024SOU EXTENSION 1 GRANTED
Monday, March 18, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 18, 2024SOU EXTENSION 1 FILED
Tuesday, March 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 21, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, October 29, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 29, 2024PETITION TO REVIVE-GRANTED
Tuesday, October 29, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, October 29, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION

Related Keywords

screen preeclampsia encompass purposes treatment diagnostic testing medical